Read + Share
Wang L, Lyu C, Stadlbauer B, Buchner A, et al. Berbamine targets cancer stem cells and reverses cabazitaxel resistance via
inhibiting IGF2BP1 and p-STAT3 in prostate cancer. Prostate 2023 Oct 12. doi: 10.1002/pros.24632.
PMID: 37828768
|
 |
|
Wang L, Lyu C, Stadlbauer B, Buchner A, et al. Berbamine targets cancer stem cells and reverses cabazitaxel resistance via
inhibiting IGF2BP1 and p-STAT3 in prostate cancer. Prostate 2023 Oct 12. doi: 10.1002/pros.24632.
PMID: 37828768
|
|
|
|